Apollo Hospitals Enterprise Ltd.
ISIN: INE437A01024 • Market Cap: ₹1.27 Lakh Cr
The 5-Pillar Quality Audit for Apollo Hospitals Enterprise Ltd.
Evaluated across Profitability, Financial Health, Historical Compounding, Valuation Safety, and Ownership Governance:
1. Profitability & Capital Efficiency
Weight: 25%Measures operating margins (15.2%), Return on Capital Employed (19.1%), and equity compounding (20.5%).
2. Financial Health & Solvency
Weight: 25%Debt-to-Equity is 0.62 with comfortable interest coverage and clean working capital.
3. Growth & Compounding Track Record
Weight: 20%Historical 3Y Sales CAGR (11.5%) and 3Y PAT CAGR (33.3%).
4. Valuation Multiple & Margin of Safety
Weight: 15%Trades at P/E of 60.55 vs PEG of 3.42 and Dividend Yield of 0.2%.
5. Ownership Quality & Governance
Weight: 15%Promoter holding stands at 28.0%, backed by 65.4% institutional ownership.
Key Fundamental Strengths
Robust Equity Compounding (ROE: 20.5%)
Shareholder equity compounds at a healthy 20.5%, exceeding average Indian equity benchmarks.
High-Velocity Profit Compounding (3Y PAT CAGR: 33.3%)
Net earnings have compounded at 33.3% annualized, demonstrating operating leverage.
Deep Institutional Sponsorship (65.4%)
Mutual funds, domestic DIIs, and foreign FIIs hold 65.4%, providing strong governance scrutiny.
Areas to Watch & Potential Risks
Sectoral & Macro Headwinds (Healthcare)
Subject to broader cyclical demand, raw material price shifts, and regulatory frameworks governing the Healthcare space.
Quantitative Strategy Eligibility
Checking APOLLOHOSP against established Indian wealth creation frameworks:
Coffee Can Investing Framework
Passes Saurabh Mukherjea's Coffee Can rule: 10%+ sustained revenue growth and 15%+ ROCE/ROE.
Quality Factor Screener (High RoIC + Low Debt)
Scorecard of 70/100 or leverage profile sits below strict quality index hurdles.
GARP / Value-Growth Blend
Valuation multiple or return metrics require further cyclical pullback.
Healthcare Sector Peer Comparison
Compare APOLLOHOSP directly against top industry peers by market capitalization:
| Company | 5-Pillar Score | Market Cap | P/E | ROCE | D/E | Scorecard |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd. (APOLLOHOSP)Current | 70/100 | ₹1.27 Lakh Cr | 60.55 | 19.1% | 0.62 | — |
| Sun Pharmaceutical Industries Ltd. (SUNPHARMA) | 77/100 | ₹4.55 Lakh Cr | 37.65 | 20.4% | 0.05 | View |
| Divi's Laboratories Ltd. (DIVISLAB) | 73/100 | ₹2.26 Lakh Cr | 77.37 | 19.4% | 0.00 | View |
| Torrent Pharmaceuticals Ltd. (TORNTPHARM) | 64/100 | ₹1.91 Lakh Cr | 87.43 | 9.5% | 1.76 | View |
| Cipla Ltd. (CIPLA) | 63/100 | ₹1.14 Lakh Cr | 33.94 | 16.1% | 0.01 | View |
| Zydus Lifesciences Ltd. (ZYDUSLIFE) | 79/100 | ₹1.10 Lakh Cr | 24.42 | 21.9% | 0.43 | View |
Frequently Asked Questions: Apollo Hospitals Enterprise Ltd.
Q:What is the 5-Pillar Fundamental Score for Apollo Hospitals Enterprise Ltd. (APOLLOHOSP)?
Apollo Hospitals Enterprise Ltd. has a RupeeTools Fundamental Score of 70/100, placing it in the 'Solid & Healthy' category. Its pillar scores are: Profitability (76/100), Financial Health (72/100), Growth (85/100), Valuation (32/100), and Ownership Quality (72/100).
Q:Is APOLLOHOSP fundamentally strong for long-term investment?
Yes, APOLLOHOSP exhibits solid fundamental strength with a 70/100 score, driven by a return on equity of 20.5% and a debt-to-equity ratio of 0.62.
Q:Does APOLLOHOSP pass the Coffee Can Investing filter?
Yes! APOLLOHOSP satisfies both core pillars of Coffee Can Investing: achieving consistently high capital returns (ROCE/ROE >= 15%) alongside double-digit multi-year revenue growth.
Q:How does APOLLOHOSP compare against other Healthcare peers?
Within India's Healthcare sector, APOLLOHOSP trades at a P/E of 60.55 and generates an ROCE of 19.1%. Compare its 5-Pillar score of 70/100 against top sector peers like Sun Pharmaceutical Industries Ltd. (77/100), Divi's Laboratories Ltd. (73/100).
Regulatory & SEBI Research Analyst Compliance Disclaimer:
This 5-pillar fundamental score is an automated quantitative health check generated purely from historical public financial statements, corporate filings, and exchange disclosures for educational and informational purposes only. It does NOT constitute investment advice, a stock recommendation, or a solicitation to buy or sell securities. RupeeTools is not a SEBI-registered Research Analyst. Please consult a SEBI-registered financial advisor before making investment decisions.